Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha

Experimental Cell Research

Volumn 284, Issue 2, 2003, Pages 209-221

  Evstafieva, Alexandra G ^a   Belov, George A ^a,b   Rubtsov, Yuri P ^a   Kalkum, Markus ^c   Joseph, Bertrand ^d   Chichkova, Nina V ^a   Sukhacheva, Elena A ^e   Bogdanov, Alexey A ^a   Pettersson, Ralf F ^d   Agol, Vadim I ^a,b   Vartapetian, Andrey B ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

^c ROCKEFELLER UNIVERSITY   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Apoptosis; Caspase 3; Intracellular trafficking; Prothymosin ; Surface exposure

Indexed keywords

CASPASE 3; MONOCLONAL ANTIBODY; MUTANT PROTEIN; PROTHYMOSIN ALPHA; TUMOR NECROSIS FACTOR;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION;

EID: 0037376987     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00047-2     Document Type: Article

References (42)

1. Haritos A.A., Blacher R., Stein S., Caldarella J., Horecker B.L. Primary structure of rat thymus prothymosin alpha. Proc. Natl. Acad. Sci. USA. 82:1985;343-346.
2. Watts J.D., Cary P.D., Sautiere P., Crane-Robinson C. Thymosins both nuclear and cytoplasmic proteins . Eur. J. Biochem. 192:1990;643-651.
3. Manrow R.E., Sburlati A.R., Hanover J.A., Berger S.L. Nuclear targeting of prothymosin alpha. J. Biol. Chem. 266:1991;3916-3924.
4. Clinton M., Graeve L., el-Dorry H., Rodriguez-Boulan E., Horecker B.L. Evidence for nuclear targeting of prothymosin and parathymosin synthesized in situ. Proc. Natl. Acad. Sci. USA. 88:1991;6608-6612.
5. Gomez-Marquez J., Segade F., Dosil M., Pichel J.G., Bustelo X.R., Freire M. The expression of prothymosin alpha gene in T lymphocytes and leukemic lymphoid cells is tied to lymphocyte proliferation. J. Biol. Chem. 264:1989;8451-8454.
6. Gast K., Damaschun H., Eckert K., Schulze-Forster K., Maurer H.R., Muller-Frohne M., Zirwer D., Czarnecki J., Damaschun G. Prothymosin alpha a biologically active protein with random coil conformation . Biochemistry. 34:1995;13211-13218.
7. Rubtsov Y.P., Zolotukhin A.S., Vorobjev I.A., Chichkova N.V., Pavlov N.A., Karger E.M., Evstafieva A.G., Felber B.K., Vartapetian A.B. Mutational analysis of human prothymosin alpha reveals a bipartite nuclear localization signal. FEBS Lett. 413:1997;135-141.
8. Tsitsiloni O.E., Stiakakis J., Koutselinis A., Gogas J., Markopoulos C., Yialouris P., Bekris S., Panoussopoulos D., Kiortsis V., Voelter W., Haritos A.A. Expression of alpha-thymosins in human tissues in normal and abnormal growth. Proc. Natl. Acad. Sci. USA. 90:1993;9504-9507.
9. Sburlati A.R., De La Rosa A., Batey D.W., Kurys G.L., Manrow R.E., Pannell L.K., Martin B.M., Sheeley D.M., Berger S.L. Phosphorylation of human and bovine prothymosin alpha in vivo. Biochemistry. 32:1993;4587-4596.
10. Lukashev D.E., Chichkova N.V., Vartapetian A.B. Multiple tRNA attachment sites in prothymosin alpha. FEBS Lett. 451:1999;118-124.
11. Eilers M., Schirm S., Bishop J.M. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10:1991;133-141.
12. Eschenfeldt W.H., Berger S.L. The human prothymosin alpha gene is polymorphic and induced upon growth stimulation evidence using a cloned cDNA . Proc. Natl. Acad. Sci. USA. 83:1986;9403-9407.
13. Wu C.-L., Shiau A.-L., Lin C.-S. Prothymosin alpha promotes cell proliferation in NIH3T3 cells. Life Sci. 61:1997;2091-2101.
14. Rodriguez P., Vinuela J.E., Alvarez-Fernandez L., Buceta M., Vidal A., Dominguez F., Gomez-Marquez J. Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cells. Biochem. J. 331:1998;753-761.
15. Sburlati A.R., Manrow R.E., Berger S.L. Prothymosin alpha antisense oligomers inhibit myeloma cell division. Proc. Natl. Acad. Sci. USA. 88:1991;253-257.
16. Rodriguez P., Vinuela J.E., Alvarez-Fernandez L., Gomez-Marquez J. Prothymosin alpha antisense oligonucleotides induce apoptosis in HL-60 cells. Cell Death Differ. 6:1999;3-5.
17. Orre R.S., Cotter M.A. II, Subramanian C., Robertson E.S. Prothymosin alpha functions as a cellular oncoprotein by inducing transformation of rodent fibroblasts in vitro. J. Biol. Chem. 276:2001;1794-1799.
18. Martini P.G., Delage-Mourroux R., Kraichely D.M., Katzenellenbogen B.S. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol. Cell. Biol. 20:2000;6224-6232.
19. Vareli K., Frangou-Lazaridis M., van der Kraan I., Tsolas O., van Driel R. Nuclear distribution of prothymosin alpha and parathymosin evidence that prothymosin alpha is associated with RNA synthesis processing and parathymosin with early DNA replication . Exp. Cell Res. 257:2000;152-161.
20. Karetsou Z., Kretsovali A., Murphy C., Tsolas O., Papamarcaki T. Prothymosin alpha interacts with the CREB-binding protein and potentiates transcription. EMBO Rep. 3:2002;361-366.
21. Freire M., Rey-Mendez M., Gomez-Marquez J., Arias P. Evidence for the synthesis of thymosin alpha 1 by calf thymocytes and the production of this peptide by natural processing. Arch. Biochem. Biophys. 239:1985;480-485.
22. Naylor P.H., Friedman-Kien A., Hersh E., Erdos M., Goldstein A.L. Thymosin alpha 1 and thymosin beta 4 in serum comparison of normal, cord, homosexual and AIDS serum . Int. J. Immunopharmacol. 8:1986;667-676.
23. Sztein M.B., Serrate S.A. Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes. Int. J. Immunopharmacol. 11:1989;789-800.
24. Baxevanis C.N., Frillingos S., Seferiadis K., Reclos G.J., Arsenis P., Katsiyiannis A., Anastasopoulos E., Tsolas O., Papamichail M. Enhancement of human T lymphocyte function by prothymosin alpha increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytes . Immunopharmacol. Immunotoxicol. 12:1990;595-617.
25. Evstafieva A.G., Belov G.A., Kalkum M., Chichkova N.V., Bogdanov A.A., Agol V.I., Vartapetian A.B. Prothymosin alpha fragmentation in apoptosis. FEBS Lett. 467:2000;150-154.
26. Enkemann S.A., Wang R.H., Trumbore M.W., Berger S.L. Functional discontinuities in prothymosin alpha caused by caspase cleavage in apoptotic cells. J. Cell. Physiol. 182:2000;256-268.
27. Tolskaya E.A., Romanova L.I., Kolesnikova M.S., Ivannikova T.A., Smirnova E.A., Raikhlin N.T., Agol V.I. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J. Virol. 69:1995;1181-1189.
28. Sukhacheva E.A., Evstafieva A.G., Fateeva T.V., Shakulov V.R., Efimova N.A., Karapetian R.N., Rubtsov Y.P., Vartapetian A.B. Sensing prothymosin alpha origin, mutations and conformation with monoclonal antibodies. J. Immunol. Meth. 266:2002;185-196.
29. Grigorieva J.A., Dainiak M.B., Katrukha A.G., Muronetz V.I. Antibodies to the nonnative forms of D-glyceraldehyde-3-phosphate dehydrogenase identification, purification, and influence on the renaturation of the enzyme . Arch. Biochem. Biophys. 369:1999;252-260.
30. Evstafieva A.G., Chichkova N.V., Makarova T.N., Vartapetian A.B., Vasilenko A.V., Abramov V.M., Bogdanov A.A. Overproduction in Escherichia coli, purification and properties of human prothymosin alpha. Eur. J. Biochem. 231:1995;639-643.
31. Spengler B., Kirsch D., Kaufmann R. Metastable decay of peptides and proteins in matrix-assisted laser-desorption mass spectometry. Rapid Commun. Mass Spectrom. 5:1991;198-202.
32. Faleiro L., Lazebnik Y. Caspases disrupt the nuclear-cytoplasmic barrier. J. Cell Biol. 151:2000;951-959.
33. Kuida K., Lippke J.A., Ku G., Harding M.W., Livingston D.J., Su M.S., Flavell R.A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 267:1995;2000-2003.
34. Ghayur T., Banerjee S., Hugunin M., Butler D., Herzog L., Carter A., Quintal L., Sekut L., Talanian R., Paskind M., Wong W., Kamen R., Tracey D., Allen H. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature. 386:1997;619-623.
35. Zhang Y., Center D.M., Wu D.M., Cruikshank W.W., Yuan J., Andrews D.W., Kornfeld H. Processing and activation of pro-interleukin-16 by caspase-3. J. Biol. Chem. 273:1998;1144-1149.
36. Knies U.E., Behrensdorf H.A., Mitchell C.A., Deutsch U., Risau W., Drexler H.C., Clauss M. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc. Natl. Acad. Sci. USA. 95:1998;12322-12327.
37. Shalak V., Kaminska M., Mitnacht-Kraus R., Vandenabeele P., Clauss M., Mirande M. The EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component. J. Biol. Chem. 276:2001;23769-23776.
38. Hoffmann P.R., deCathelineau A.M., Ogden C.A., Leverrier Y., Bratton D.L., Daleke D.L., Ridley A.J., Fadok V.A., Henson P.M. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155:2001;649-659.
39. Platt N., da Silva R.P., Gordon S. Recognizing death the phagocytosis of apoptotic cells . Trends Cell Biol. 8:1998;365-372.
40. Li F., Ackermann E.J., Bennett C.F., Rothermel A.L., Plescia J., Tognin S., Villa A., Marchisio P.C., Altieri D.C. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nature Cell Biol. 1:1999;461-466.
41. Levkau B., Koyama H., Raines E.W., Clurman B.E., Herren B., Orth K., Roberts J.M., Ross R. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2 role of a caspase cascade . Mol. Cell. 1:1998;553-563.
42. Asada M., Yamada T., Ichijo H., Delia D., Miyazono K., Fukumuro K., Mizutani S. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18:1999;1223-1234.